{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:48:26Z","timestamp":1786373306490,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.2215\/cjn.10441013","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T01:17:22Z","timestamp":1407460642000},"page":"1676-1683","source":"Crossref","is-referenced-by-count":56,"title":["Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction"],"prefix":"10.2215","volume":"9","author":[{"given":"Ellen K.","family":"Hoogeveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Geleijnse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Kromhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Stijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie F.","family":"Gemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Giltay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20230601","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/sj.ki.5002374","article-title":"Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study.","volume":"72","author":"Wetzels","year":"2007","journal-title":"Kidney Int"},{"key":"R2-4-20230601","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/ndt\/gfn148","article-title":"Predictors of change in estimated GFR: A population-based 7-year follow-up from the Tromso study.","volume":"23","author":"Kronborg","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R3-4-20230601","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2215\/CJN.05700611","article-title":"Obesity and mortality risk among younger dialysis patients.","volume":"7","author":"Hoogeveen","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-4-20230601","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2007.02.047","article-title":"Effect of first myocardial ischemic event on renal function.","volume":"100","author":"Eijkelkamp","year":"2007","journal-title":"Am J Cardiol"},{"key":"R5-4-20230601","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R6-4-20230601","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"R7-4-20230601","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2005090986","article-title":"Mortality risk stratification in chronic kidney disease: One size for all ages?","volume":"17","author":"O\u2019Hare","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R8-4-20230601","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archinte.168.8.832","article-title":"Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.","volume":"168","author":"Appel","year":"2008","journal-title":"Arch Intern Med"},{"key":"R9-4-20230601","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1017\/S0007114510005040","article-title":"Consumption of long-chain n-3 PUFA, \u03b1-linolenic acid and fish is associated with the prevalence of chronic kidney disease.","volume":"105","author":"Gopinath","year":"2011","journal-title":"Br J Nutr"},{"key":"R10-4-20230601","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1373\/clinchem.2007.095521","article-title":"Plasma polyunsaturated fatty acids and the decline of renal function.","volume":"54","author":"Lauretani","year":"2008","journal-title":"Clin Chem"},{"key":"R11-4-20230601","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"n-3 fatty acids and cardiovascular events after myocardial infarction.","volume":"363","author":"Kromhout","year":"2010","journal-title":"N Engl J Med"},{"key":"R12-4-20230601","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ahj.2009.12.033","article-title":"Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: Design and baseline characteristics of the Alpha Omega Trial.","volume":"159","author":"Geleijnse","year":"2010","journal-title":"Am Heart J"},{"key":"R13-4-20230601","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1373\/49.4.652","article-title":"High stability of markers of cardiovascular risk in blood samples.","volume":"49","author":"Giltay","year":"2003","journal-title":"Clin Chem"},{"key":"R14-4-20230601","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function.","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"R15-4-20230601","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"R16-4-20230601","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1515\/CCLM.2010.318","article-title":"First certified reference material for cystatin C in human serum ERM-DA471\/IFCC.","volume":"48","author":"Grubb","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"R17-4-20230601","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"R19-4-20230601","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc12-1940","article-title":"The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: Results of the GO-FISH trial.","volume":"36","author":"Miller","year":"2013","journal-title":"Diabetes Care"},{"key":"R20-4-20230601","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2215\/CJN.07650711","article-title":"Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.","volume":"7","author":"Zoppini","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R21-4-20230601","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/sim.3603","article-title":"Measurement in clinical trials: A neglected issue for statisticians?","volume":"28","author":"Senn","year":"2009","journal-title":"Stat Med"},{"key":"R22-4-20230601","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"Effect of lipid reduction on the progression of renal disease: A meta-analysis.","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"key":"R23-4-20230601","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ndt\/gfl744","article-title":"Association of cystatin C and estimated GFR with inflammatory biomarkers: The Heart and Soul Study.","volume":"22","author":"Singh","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R24-4-20230601","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD.","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R25-4-20230601","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365513.2010.546879","article-title":"Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation.","volume":"71","author":"Grubb","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"R26-4-20230601","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3945\/jn.108.100354","article-title":"DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men.","volume":"139","author":"Kelley","year":"2009","journal-title":"J Nutr"},{"key":"R27-4-20230601","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0955-2863(03)00101-3","article-title":"Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT.","volume":"14","author":"Ciubotaru","year":"2003","journal-title":"J Nutr Biochem"},{"key":"R28-4-20230601","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0008-6363(01)00406-0","article-title":"Longchain n-3 polyunsaturated fatty acids and blood vessel function.","volume":"52","author":"Abeywardena","year":"2001","journal-title":"Cardiovasc Res"},{"key":"R29-4-20230601","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/eurheartj\/ehr362","article-title":"Fish oil and omega-3 fatty acids in cardiovascular disease: Do they really work?","volume":"33","author":"Kromhout","year":"2012","journal-title":"Eur Heart J"},{"key":"R30-4-20230601","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jnutbio.2009.12.004","article-title":"Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.","volume":"21","author":"Adkins","year":"2010","journal-title":"J Nutr Biochem"},{"key":"R31-4-20230601","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2010.03.009","article-title":"Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.","volume":"56","author":"Fassett","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R32-4-20230601","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199411033311804","article-title":"A controlled trial of fish oil in IgA nephropathy.","volume":"331","author":"Donadio","year":"1994","journal-title":"N Engl J Med"},{"key":"R33-4-20230601","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1681\/ASN.V124791","article-title":"A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.","volume":"12","author":"Donadio","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R34-4-20230601","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ndt\/gfn454","article-title":"Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial.","volume":"24","author":"Ferraro","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R35-4-20230601","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1464-5491.2009.02869.x","article-title":"Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus.","volume":"27","author":"Wong","year":"2010","journal-title":"Diabet Med"},{"key":"R36-4-20230601","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3945\/ajcn.2008.26867","article-title":"The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: Meta-analysis of clinical trials.","volume":"89","author":"Miller","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R37-4-20230601","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3945\/ajcn.111.025924","article-title":"Effects of n-3 PUFA supplementation on plasma soluble adhesion molecules: A meta-analysis of randomized controlled trials.","volume":"95","author":"Yang","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"R38-4-20230601","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00004872-200208000-00010","article-title":"Blood pressure response to fish oil supplementation: Metaregression analysis of randomized trials.","volume":"20","author":"Geleijnse","year":"2002","journal-title":"J Hypertens"},{"key":"R39-4-20230601","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"R40-4-20230601","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0007114512004606","article-title":"Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome.","volume":"110","author":"Aukema","year":"2013","journal-title":"Br J Nutr"},{"key":"R42-4-20230601","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1681\/ASN.2004100854","article-title":"Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study.","volume":"16","author":"Perkins","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201410000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:35Z","timestamp":1786369475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201410000-00004"}},"subtitle":["The Alpha Omega Trial"],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.10441013","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}